COMPANY
Endo Pharmaceuticals, Inc.
Endo Pharmaceuticals, Inc.: recalling firm for Calcitonin, as stated by public registers.
RECALLING FIRM
Recalled a product naming the peptide (FDA enforcement report).
| Calcitonin | Class II recall, Terminated, 2023-04-05 Regulator openFDA |
|---|
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.